Sort by
Refine Your Search
-
Listed
-
Field
-
source of information and advice to other members of the group on scientific protocols and experimental techniques. You will hold a PhD/DPhil (or near completion) in a biomedical discipline with direct
-
immunologist with a strong interest in T cell biology and immune regulation. The ideal candidate will have: • A PhD (or be close to completion) in immunology or a related biomedical field
-
. You will work with limited supervision to design and accurately execute experiments to achieve the goals of the project. Applicants should hold, or be close to completion of, PhD in Biology or a related
-
, under the direction of Prof. Sam Wolfe. It is essential to have a first degree in Linguistics, Modern Languages, Psychology, or a related discipline, possess or be very close to obtaining a PhD in
-
an opportunity to be involved in analysing the quantitative data collected as part of the project. You will hold a relevant PhD qualification (or be close to completion), with sufficient relevant research
-
group here About you Applicants must hold a PhD in Chemistry or a relevant subject area, (or be close to completion) prior to taking up the appointment. The research requires experience in inert
-
://baldwinlab.chem.ox.ac.uk/. About you Applicants must hold a PhD Biophysics, Chemistry or a related area, or be close to completion, prior to taking up your appointment. The research requires experience in NMR, familiarity
-
of the intellectual environment, capital equipment, technical expertise and excellent infrastructure in place at the MRC BNDU and OxCIN. In addition to having a PhD (or M.D.) or equivalent qualification in a relevant
-
We are seeking to appoint a highly motivated Postdoctoral Researcher to join the research group of Professor Ignacio Melero, MD PhD, at the Oxford Centre for Immuno-Oncology within the Nuffield
-
the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza virus (https://www.nature.com/articles/s41467-018-06228-8) and the technology has